A randomized controlled phase II trial of riluzole in early multiple sclerosis

OBJECTIVES: We evaluated the effect of riluzole versus placebo added to weekly IM interferon beta-1a in early multiple sclerosis (MS). METHODS: This is a randomized (1:1), double-blind, placebo-controlled trial of riluzole 50 mg twice daily in subjects with MS onset less than 1 year prior. Trial par...

Descripción completa

Detalles Bibliográficos
Autores principales: Waubant, Emmanuelle, Maghzi, Amir-Hadi, Revirajan, Nisha, Spain, Rebecca, Julian, Laura, Mowry, Ellen M, Marcus, Jacqueline, Liu, Shuang, Jin, Chengshi, Green, Ari, McCulloch, Charles E, Pelletier, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184685/
https://www.ncbi.nlm.nih.gov/pubmed/25356404
http://dx.doi.org/10.1002/acn3.60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184685/
https://www.ncbi.nlm.nih.gov/pubmed/25356404
http://dx.doi.org/10.1002/acn3.60

Ejemplares similares